Akebia Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Akebia Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q3 2024.
  • Akebia Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -20.6 %, a 1.25% increase year-over-year.
  • Akebia Therapeutics, Inc. annual Return On Assets for 2023 was -20.5 %, a 1.99% decline from 2022.
  • Akebia Therapeutics, Inc. annual Return On Assets for 2022 was -20.1 %, a 57.7% increase from 2021.
  • Akebia Therapeutics, Inc. annual Return On Assets for 2021 was -47.6 %, a 11.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -20.6 +0.26 +1.25% Jul 1, 2024 Sep 30, 2024
Q2 2024 -17.5 +11.9 +40.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -18 -3.71 -25.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -20.5 -0.4 -1.99% Oct 1, 2023 Dec 31, 2023
Q3 2023 -20.8 +10.1 +32.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -29.4 +0.25 +0.84% Apr 1, 2023 Jun 30, 2023
Q1 2023 -14.3 +34 +70.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -20.1 +27.4 +57.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.9 +17.2 +35.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.7 +17.1 +36.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.3 +9.94 +17.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -47.6 +6.2 +11.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -48.1 +4.35 +8.29% Jul 1, 2021 Sep 30, 2021
Q2 2021 -46.8 +2.97 +5.97% Apr 1, 2021 Jun 30, 2021
Q1 2021 -58.2 -24.5 -72.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -53.8 -19.7 -57.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -52.5 -24.5 -87.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -49.8 -21.9 -78.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -33.7 -5.25 -18.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -34.1 -8.65 -34% Oct 1, 2019 Dec 31, 2019
Q3 2019 -28 -11.2 -67.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -27.8 -11.1 -66.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -28.5 -14.3 -101% Jan 1, 2019 Mar 31, 2019
Q4 2018 -25.5 -2.76 -12.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -16.8 +24.4 +59.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -16.7 +36 +68.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -14.2 +52.7 +78.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -22.7 +38.6 +63% Oct 1, 2017 Dec 31, 2017
Q3 2017 -41.2 +23.4 +36.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -52.7 +3.44 +6.13% Apr 1, 2017 Jun 30, 2017
Q1 2017 -66.9 -22.2 -49.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -61.3 -18 -41.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -64.6 -25.9 -67% Jul 1, 2016 Sep 30, 2016
Q2 2016 -56.1 -22.6 -67.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -44.6 -11.6 -35.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -43.2 -13.1 -43.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -38.7 -7.27 -23.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -33.5 Apr 1, 2015 Jun 30, 2015
Q1 2015 -33 Jan 1, 2015 Mar 31, 2015
Q4 2014 -30.1 Oct 1, 2014 Dec 31, 2014
Q3 2014 -31.4 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.